Demonstrated safety with daily subcutaneous (SC) injections of Kineret (R) (Anakinra "C recombinant interleukin-1 receptor antagonist) in a standard practice population
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- July 1, 2003
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1117 Public Health and Health Services (FoR)
- Arthritis & Rheumatology (Science Metrix)
published in
- Annals of the Rheumatic Diseases Journal
presented at event
- Annual European Congress of Rheumatology Conference